ストックスクリーナーアプリを入手
0.9487
8.78%
-0.0914
アフターアワーズ：
.96
0.0114
+1.20%
前日終値:
$1.04
開ける：
$1.0371
24時間の取引高:
166.58K
Relative Volume:
0.75
時価総額：
$24.00M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-11.34%
1か月 パフォーマンス:
-13.80%
6か月 パフォーマンス:
+37.65%
1年 パフォーマンス:
-90.31%
1日の値動き範囲:
$0.9112
$1.0371
1週間の範囲:
$0.9112
$1.13
52週間の値動き範囲:
$0.375
$9.7128
AEON Biopharma Inc. Stock (AEON) Company Profile
Compare AEON vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AEON
AEON Biopharma Inc.
|
0.9487 | 26.32M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-08-18 | 開始されました | H.C. Wainwright | Buy |
AEON Biopharma Inc. (AEON) 最新ニュース
Short Covering: Can AEON Biopharma Inc. weather a recessionWeekly Trading Summary & Weekly Watchlist of Top Performers - baoquankhu1.vn
Profit Review: Is AEON Biopharma Inc in a long term uptrendMarket Sentiment Summary & Daily Stock Trend Reports - baoquankhu1.vn
Midday Stock Roundup: MDxHealth Up 9% Since Preliminary Q4, FY Results - Orange County Business Journal
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions - The Manila Times
AEON Biopharma completes FDA meeting, shareholders approve transactions - Investing.com
Aeon Biopharma stock falls after FDA meeting and debt restructuring By Investing.com - Investing.com Nigeria
Aeon Biopharma stock falls after FDA meeting and debt restructuring - Investing.com
Aeon Biopharma Reports bpd Type 2A Meeting With FDA And Shareholder Approval Of The November Transactions - TradingView
AEON Biopharma completes FDA meeting, shareholders approve transactions By Investing.com - Investing.com Nigeria
Shareholders back AEON debt-cut deals after FDA meeting on Botox biosimilar - Stock Titan
Growth Value: Is AEON Biopharma Inc stock good for income investorsQuarterly Trade Summary & Community Supported Trade Ideas - baoquankhu1.vn
Is EverQuote Inc. stock attractive for passive investorsWeekly Investment Summary & Long-Term Safe Return Strategies - bollywoodhelpline.com
Midday Stock Roundup: loanDepot Jumps on Trump’s Proposed Mortgage Plan - Orange County Business Journal
Rate Cut: Whats the MACD signal for AEON Biopharma Inc2025 Macro Impact & AI Powered Market Entry Ideas - baoquankhu1.vn
Do Not Use - ocbj.com
Market Wrap: Can AEON Biopharma Inc keep up with sector leadersJuly 2025 Rallies & Risk Controlled Swing Alerts - baoquankhu1.vn
AEON Biopharma (AEON) Price Target Decreased by 14.75% to 5.30 - Nasdaq
Midday Stock Roundup: Staar Down 4% on Board Changes - Orange County Business Journal
AEON Biopharma Releases Updated Investor Presentation Under Reg FD - TipRanks
AEON Biopharma, Inc. Unveils Biosimilar Strategy for ABP-450 - TradingView
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week - MSN
Midday Stock Roundup: loanDepot Rises on Trump Move - Orange County Business Journal
AEON Biopharma (NASDAQ:AEON) & Synaptogenix (NASDAQ:TAOX) Head to Head Analysis - Defense World
Why AEON Biopharma Inc. Class stock stays on buy listsJuly 2025 Trends & Low Drawdown Investment Ideas - Улправда
Will AEON Biopharma Inc. Class stock outperform foreign stocksWeekly Stock Report & Low Drawdown Trading Strategies - Улправда
What technical signals suggest for AEON Biopharma Inc. stockGDP Growth & Momentum Based Trading Ideas - Улправда
What dividend safety rating applies to AEON Biopharma Inc. Class stockWeekly Earnings Recap & Low Risk Entry Point Guides - Улправда
AEON Biopharma, Inc. Class A Common Stock (NY: AEON - FinancialContent
What insider trading reveals about AEON Biopharma Inc. stockHigh Yield Income Stocks & Ride the Wave of Market-Beating Growth - Улправда
2026 world cup star players explained: How AEON Biopharma Inc. Class stock compares with tech leaders2026 world cup usa national team third place match key players pressing system expert forecast preview - ulpravda.ru
2026 world cup match report guide: How AEON Biopharma Inc. stock benefits from global expansion2026 world cup usa national team semifinals defensive leaders pressing system winner prediction preview - Улправда
Can AEON Biopharma Inc. Class stock stage a strong rebound this quarter2026 world cup usa national team qualification playmakers high defensive line odds analysis preview - Улправда
Midday Stock Roundup: Rivian Down on Production Totals - Orange County Business Journal
AEON Biopharma, Inc. (AEON) Stock Forecast & Price Prediction 2025–2030 - CoinCodex
AEON Biopharma (NASDAQ:AEON) Trading Up 5.9% – Time to Buy? - Defense World
AEON Biopharma (AEON) seeks shareholder approval for PIPE, note exchange and equity plan - Stock Titan
Will AEON Biopharma Inc. stock split attract more investorsMarket Sentiment Indicators & Calculate Profit Targets With AI Accuracy - bollywoodhelpline.com
Midday Stock Roundup: Shimmick Corp. climbs 14% - Orange County Business Journal
Aug EndMonth: How AEON Biopharma Inc stock benefits from global expansionWeekly Profit Recap & Risk Managed Investment Strategies - moha.gov.vn
Insider Buy: Can AEON Biopharma Inc Class stock stage a strong rebound this quarterJuly 2025 Rallies & Low Drawdown Trading Techniques - moha.gov.vn
Is AEON Biopharma Inc. Class stock bottoming after sell offBond Market & Community Verified Trade Signals - Улправда
Investor Mood: Can AEON Biopharma Inc. Class stock stage a strong rebound this quarter - Улправда
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - The Manila Times
How AEON Biopharma Inc. stock benefits from global expansionEarnings Recap Summary & Weekly High Potential Stock Alerts - Улправда
AEONAeon Biopharma Latest Stock News & Market Updates - Stock Titan
Will AEON Biopharma Inc. Class stock benefit from infrastructure billWeekly Trading Summary & Reliable Breakout Stock Forecasts - Улправда
Biopharmaceutical company offers new hires stock units over four years - Stock Titan
AEON Biopharma Inc. (AEON) 財務データ
AEON Biopharma Inc. (AEON) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.24%
0.19%
大文字化:
|
ボリューム (24 時間):